Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.
Russell S, Duquette M, Liu J, Drapkin R, Lawler J, Petrik J.
Russell S, et al. Among authors: lawler j.
FASEB J. 2015 Feb;29(2):576-88. doi: 10.1096/fj.14-261636. Epub 2014 Nov 13.
FASEB J. 2015.
PMID: 25395453
Free PMC article.
In this study, we describe a novel treatment approach and mechanism of action with 3TSR and chemotherapy that induces regression of advanced stage EOC and significantly improves survival.-Russell, S., Duquette, M., Liu, J., Drapkin, R., Lawler, J., Petrik, …
In this study, we describe a novel treatment approach and mechanism of action with 3TSR and chemotherapy that induces regression of advanced …